FUSN Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own FUSN shares is 140, representing 86.8% of the company's common stock.

PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC, in the last quarter, reduced its stake in FUSN by -63.91% restricting it's holding to 563.39 thousand shares of worth nearly $12.01M. SPHERA FUNDS MANAGEMENT LTD. also lessened -58.64% of the FUSN shares from its portfolio, reducing its holding to 449.04 thousand shares of worth $9.57M. FEDERATED HERMES, INC. also shunned FUSN shares holding by -0.69% last quarter which brought its holding to 10.81 million shares worth $230.49M.

As per its latest 13F filing, AXA S.A. increased its stake in FUSN by 100% in the last quarter. The institutional holder raised its holding to 164.52 thousand shares having worth more than $3.51M. VANGUARD GROUP INC also added 100% more shares of FUSN to its portfolio, raising its holding to 33.04 thousand shares of worth $704.33K. BELVEDERE TRADING LLC also increased its FUSN shares holding by 101.85% which brought its holding to 33 thousand shares worth $703.56K.

The insider with the most stakes in FUSN is Christenson Johan , director at the company. Additionally, FUSN stock is highly held by 10 percent owner HealthCap VII, L.P. and 10 percent owner JOHNSON & JOHNSON among others.

Company executives, directors, and other insiders own 0.47% percent of Fusion Pharmaceuticals Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which FUSN insiders have sold stock, totaling 0 shares. Insiders that have sold shares include VALLIANT JOHN and ADAMS STREET PARTNERS LLC.

There have been 0 transaction(s) during the past 6-months in which Fusion Pharmaceuticals Inc. insiders have bought stock, totalling 0 shares

Around 0 Fusion Pharmaceuticals Inc. shares are held by insiders, which represents about 0.47% of FUSN stock.

FUSN director, Christenson Johan holds the largest portfolio of the company's shares. FUSN shares owned by Christenson total nearly 3.81 million.

AXA S.A. is the largest institutional owner in FUSN which holds 164.52 thousand shares worth $3.51M or 0.23% of the total FUSN shares outstanding followed by VANGUARD GROUP INC with ownership of 33.04 thousand shares representing 0.05% of the FUSN ownership. BELVEDERE TRADING LLC is the third largest stakeholder with 33 thousand shares or 0.05% of the ownership worth more than $703.56K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the FUSN is concerned, it is a stock which is not optionable.

Number of FUSN shares short is 3.06M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 85.06M shares of FUSN are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, FUSN has 61.58M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for FUSN is 6.22.